Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
about
Increasing awareness of sex differences in airway diseasesHighlight on advances in nontuberculous mycobacterial disease in North America.'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionNontuberculous Mycobacteria in Noncystic Fibrosis BronchiectasisGender susceptibility to mycobacterial infections in patients with non-CF bronchiectasisManagement of nontuberculous mycobacterial infection in the elderly.Suspecting non-cystic fibrosis bronchiectasis: What the busy primary care clinician needs to knowInfections in "noninfectious" lung diseases.Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city.Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.Gender differences in outcomes of patients with cystic fibrosisClinical findings in relation to mortality in non-tuberculous mycobacterial infections: patients with Mycobacterium avium complex have better survival than patients with other mycobacteria.Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Immunomodulatory effect of macrolides: At what cost?Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis.How I treat bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationGlobal impact of bronchiectasis and cystic fibrosis.Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives.Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry.Bronchiectasis in China.Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects.Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria.Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts.Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.[Nontuberculous mycobacterial infections].Mycobacterium avium lysate induces matrix metalloproteinase-1 in intestinal tissue and peripheral blood: observations from selected hospital based Zambian adults.Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.Gender differences in bronchiectasis: a real issue?Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.BronchiectasisImpact of concomitant nontuberculous mycobacteria and isolates in non-cystic fibrosis bronchiectasis
P2860
Q26775074-B2713BA9-53D4-401B-986F-D2C59833FA77Q27028191-2AAEF583-35EB-4D46-B073-2DFB046C22FBQ28070339-7CE3BEFA-42FA-4046-84AC-3F4CB84319AAQ28083865-853F56D0-7926-4A8E-B5FF-9E03238D8256Q28084682-F891B3F8-C6F9-479D-A3C2-22CE363B5620Q30406048-82125C22-3E95-4116-AA77-4B612874BF48Q33577663-BDC8CAEA-F27D-4A7C-BE05-2EABD87ED6BDQ34357445-5AE416B3-75AF-4C3A-99F1-E96327FD796FQ34653656-C3506274-5CB7-4693-8F13-5C3304F4E382Q35121799-B785D700-7B84-4FDA-9331-ED01C796F073Q35641585-8AD6EA24-AD30-45A3-B087-B96A4F172332Q35983388-39949AFD-A4F3-40E5-BFC9-CC00DB364534Q36109690-87887340-FDD1-4163-9883-EC246E1D0551Q36567746-5F9F9863-775D-4B1D-9AA8-3A0F3DD06990Q36766723-1AAB3311-6915-4BB7-B2E4-45F1740AC592Q37465667-23FC5841-A660-4AF2-BF06-FD05A8792DB2Q37609903-191DB4A6-2FCB-4320-82A9-ED843F036C8FQ37631978-190F5D0D-01FC-4277-92F1-B6F93CA56001Q38569772-FB3792D9-ECBA-4F32-9919-74712AD20F99Q38799847-9D4BDEE2-9E8E-415A-8B73-F3930DEFA344Q39993355-8F9B1DE3-A04E-4155-A65F-F1363D47DDD6Q41114857-E590CE7C-D42D-4BDB-8385-5C4DCC4A3404Q41993428-86A4EAAD-B072-4AE7-B5E5-1950491A7AFAQ42248571-58AC7122-0E8D-4F6F-AB24-BED270E61393Q47147744-15DF4C88-F573-4A9A-8344-1C6A298FC4ABQ47730320-4B79FF2B-4154-44A0-AD13-086EDA987552Q47756838-0C2AE4DB-3322-4372-A3D8-1355F24D5A1CQ50086071-2570B1A0-9840-4586-9DC4-9C7A73C5E152Q52691636-20E34D64-CBBF-4559-9281-E6D1E9754543Q54965235-654FDA38-9D68-42A7-BE50-E1F3932D9CA8Q55299552-BB35CB9A-8470-4A82-9C3D-D5C5FA30FC57Q55433449-3A2B976B-601A-40FB-A2BF-86F5C715C5F4Q56227159-22D053A2-80BA-4DA1-85BB-06D927DA7A8DQ58790600-9C1A42E1-B219-4149-A230-21B25D834B58
P2860
Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@ast
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@en
type
label
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@ast
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@en
prefLabel
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@ast
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@en
P2093
P2860
P1476
Non-tuberculous mycobacterial ...... ystic fibrosis bronchiectasis.
@en
P2093
Basel Ericsoussi
Daniel Rodgers
Mehdi Mirsaeidi
Ruxana T Sadikot
Walid Hadid
P2860
P304
P356
10.1016/J.IJID.2013.03.018
P577
2013-05-16T00:00:00Z